Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,734 across all filing types
Latest filing 2021-09-11 Investor Presentation
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
110年03月法人說明會簡報 — 179520210911M007.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation of the company's 2020 annual operational results and 2021 strategic goals. It includes comprehensive financial data such as revenue, gross profits, operating income, EPS, and detailed business segment performance. It also discusses market share, product development progress, and strategic initiatives. The document is titled as a "法人說明會" which translates to an investor or analyst presentation meeting, and it contains forward-looking statements and detailed financial and operational analysis typical of an investor presentation. It is not a formal annual report (10-K) or audit report, nor is it a brief earnings release or a regulatory filing. The length and content indicate it is a presentation document aimed at investors and analysts, focusing on financials, strategy, and market position.
2021-09-11 Chinese
110年03月法人說明會簡報 — 179520201117E001.pdf
Investor Presentation Classification · 95% confidence The document is titled 'THIRD QUARTER 2020 RESULTS Investor Presentation' and contains detailed financial data, business updates, pipeline information, market share statistics, and operational highlights for Q3 2020. It includes financial review sections with actual financial figures such as net sales, gross profits, operating income, EPS, and cash flow metrics. The presence of forward-looking statements, detailed agenda, and extensive business and financial analysis indicates this is a presentation aimed at investors summarizing quarterly results and business progress. The document length is substantial (15,000 characters), and it is not merely an announcement or a brief summary. Therefore, it fits the category of an Investor Presentation (IP) rather than an Earnings Release (ER) which would be shorter and less detailed, or an Interim Report (IR) which would be more formal and comprehensive. Hence, the correct classification is Investor Presentation (IP).
2021-09-11 Chinese
110年03月法人說明會簡報 — 179520201117M001.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed operational and financial performance report for Q3 2020, including comprehensive financial data such as net sales, gross profits, operating income, EPS, and detailed business segment analysis. It also includes management commentary on business growth, product development, market expansion, and strategic initiatives. The presence of extensive financial figures, quarterly period references (Q3'20), and management discussion indicates this is a comprehensive interim or quarterly report rather than a brief earnings release or presentation. The document length (11,396 characters) and depth of content support classification as an Interim / Quarterly Report (IR). Q3 2020
2021-09-11 Chinese
110年03月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing of scheduled investor presentations and meetings, including dates, times, locations, and links to presentation materials. It specifically mentions '法人說明會' which translates to 'investor presentations' or 'institutional investor meetings'. There is no detailed financial data or report content, only references to presentations and related links. The document length is short (1249 characters), and it serves as an announcement or schedule of investor presentations rather than the presentations themselves or financial reports. Therefore, the document fits the category of Investor Presentation (IP).
2021-09-11 Chinese
110年05月法人說明會簡報 — 179520210911E002.pdf
Investor Presentation Classification · 95% confidence The document is titled 'FIRST QUARTER 2021 RESULTS Investor Presentation' and contains detailed financial data, business highlights, strategic deliverables, and market analysis for Q1 2021. It includes comprehensive financial tables with net sales, gross profits, operating income, EPS, and other financial metrics for the quarter, as well as forward-looking statements and strategic information. The content is consistent with a detailed presentation aimed at investors, focusing on financial performance, business strategy, and market position for the quarter. There is no indication that this is a full annual report, audit report, or regulatory filing. The length and detail confirm it is not a brief announcement or a certification. Therefore, the document fits the definition of an Investor Presentation (IP).
2021-09-11 Chinese
110年05月法人說明會簡報 — 179520210911M002.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed presentation of the company's Q1 2021 operational and financial performance, including revenue growth, market share, product development, strategic alliances, and future plans. It contains comprehensive financial data such as net sales, gross profits, operating income, net income, and EPS for Q1 2021, along with comparisons to previous periods. The document also discusses strategic partnerships, R&D progress, and capital investments. The presence of detailed quarterly financial results and operational analysis indicates this is a comprehensive interim or quarterly report rather than a brief earnings release or an investor presentation. The length (over 14,000 characters) and depth of financial and operational data confirm it is a substantive financial report for a period shorter than a full fiscal year. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2021
2021-09-11 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.